References
- Sherman B. W., West J. H., Korenman S. G. The menopausal transition: analysis ofLH, FSH, estradiol and progesterone concentrations during menstrual cycles of older women. J. Clin. Endocrinol. Metab. 1976; 42: 629–34
- Reyes F. I., Winter J. S. D., Faiman C. Pituitary–ovarian relationships preceding the menopause. Am. J. Obstet. Gynecol. 1977; 129: 557–62
- Jaszmann L. J. B., Van Lith N. D., Zaat J. C. A. The perimenopausal symptoms. Med. Gynecol. Socio!. 1969; 4: 268–75
- Sturdee D. W., Wilson K. A., Pipili E., Crocker A. D. Physiological aspects of menopausal hot flush. Br. Med. J. 1978; 2: 79–85
- Chez R. A., Jaffe R. B., Kase N. G. The sexually active premenopausal woman. Dialogues in Oral Contraception 1976; 1(6)12–25
- Greenblatt R. B., Nezhat C., McNamara V. P. Appropriate contraception for middle-aged women. J. Biosoc. Sci. 1979; 6: 119–27
- Upton G. V. Theperimenopause: physiological correlates and clinical management. J. Re-prod. Med. 1982; 27: 1–15
- Smith D. C., Prentice R., Thompson D. G. Association of exogenous estrogen and endometrial carcinoma. N. Engl. J. Med. 1975; 293: 1164–7
- Christiansen C., Christensen M S., McNair P. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur. J. Clin. Invest. 1980; 10: 273–82
- Whitehead M. I., Townsend P. T., Pryse-Davies J. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N. Engl. J. Med. 1981; 305: 1599–1606
- Sherman B. M., Korenman S. G. Hormonal characteristics of the human menstrual cycle throughout reproductive life. J. Clin. Invest. 1985; 55: 699–706
- Ushiroyama T., Yoshikawa M., Saeki M., Okuda K., Sugimoto O. Hyper-gonadotropinemia with estradiol secretion in peri-and postmenopausal period. Acta. Obstet. Gynecol. Scand. 1989; 68: 139–45
- Huppert L. C. Hormonal replacement therapy: benefits, risks, doses. Med. Clin. North Am. 1987; 71: 23–39
- Padwich M. L., Endacott J., Whitehead M. I. Efficacy, acceptability and metabolic effects of transdermal estradiol in the management of postmenopausal women. Am. J. Obstet. Gynecol. 1985; 152: 1085–91
- Powers M. S., Schenkel L., Darley P. E. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: comparison with conventional oral estrogens used for hormone replacement. Am.J. Obstet. Gynecol. 1985; 152: 1099–1106
- Schenkel L., Balestra J., Schmitt L., Shaw J. Transdermal estrogen substitution in the menopause. Rate control in drug therapy. Proceedings of the Second Edinburgh International Conference on Drug Absorption, L. F. Pre-scott, W. S. Nimmo. Churchill Livingstone, Edinburgh 1985; 294–303
- Judd H. Efficacy of transdermal estradiol. Am.J. Obstet. Gynecol 1987; 156: 1326–30
- Furuhjelm M. Urinary excretion of hormones during the climacteric. Acta Obstet. Gynecol. Scand. 1966; 45: 352–7
- Adamopoulos D. A., Loraine J. A., Dove A. G. Endocrinological studies in women approaching the menopause. J. Obstet. Gynaecol. Br. Comm. 1971; 78: 62–79
- Metcalf M. G., Donald R. A., Livesey J. H. Pituitary–ovarian function in normal women during the menopausal transition. Clin. Endocrinol 1981; 14: 245–55
- Kamel H. E., Rebar R. W. Gonadotropin dynamics in women receiving immediate or delayed transdermal estradiol after oophorectomy. Obstet. Gynecol 1991; 72: 98–104
- Monroe S. E., Jaffe R. B., Midgley A. R. Regulation of human gonadotropins. XIII. Changes in serum gonadotropins in menstruating women in response to oophorectomy. J. Clin. Endocrinol. Metab. 1972; 34: 420–2
- Van Van Look P., Lothian H., Hunter W., Michie E., Baird D. Hypothalamic-pituitary-ovarian function in perimenopausal women. Clin. Endocrinol 1977; 7: 13–31